Jessica Hagen
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
The company’s device, Primary Relief, is the latest of DyAnsys’ long list of devices to receive FDA clearance.
The company’s Seer Home device allows for potential epilepsy diagnosis through at-home data collection.
A recent study found out-of-state telemedicine visits were most common with those who lived near a state border, and were largely for primary and mental healthcare.
A recent study found patients using virtual reality while undergoing hand surgery required less anesthesia during surgery.
The company will use the funding to support the commercial expansion of its product.
Curative is shifting from COVID-19 testing to launching a new health plan as testing needs decrease.
Amplo led the capital raise for the surrogacy connection platform.
The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.
A review of studies published in npj Digital Medicine found digital and face-to-face CBT show similar effectiveness for treating depression.